ActoGeniX's Grant - II Round

ActoGeniX raised a round of funding on August 24, 2009. Investors include VLAIO.

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics. ActoGeniX's mission is to develop and commercialize inn…

Articles about ActoGeniX's Grant - II Round: